Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -75.89%-153.27M | ---- | -59.14%-87.14M | ---- | 51.50%-54.76M | ---- | -152.71%-112.9M | ---- | 30.92%-44.68M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 50.00%-1K | ---- | 97.94%-2K | ---- | -8,640.67%-96.93K | ---- | 28.54%-1.11K | ---- | 26.45%-1.55K |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 211.96%13.73M |
| Impairment and provisions: | ---- | 938.04%54.8M | ---- | -52.80%5.28M | ---- | -85.75%11.18M | ---- | 3,925.31%78.52M | ---- | -77.70%1.95M |
| -Other impairments and provisions | ---- | 938.04%54.8M | ---- | -52.80%5.28M | ---- | -85.75%11.18M | ---- | 3,925.31%78.52M | ---- | -77.70%1.95M |
| Revaluation surplus: | ---- | 188.64%12.46M | ---- | 8,080.72%4.32M | ---- | 109.71%52.75K | ---- | 56.56%-543.21K | ---- | 82.58%-1.25M |
| -Fair value of investment properties (increase) | ---- | 192.91%12.64M | ---- | 8,080.72%4.32M | ---- | 109.71%52.75K | ---- | 56.56%-543.21K | ---- | 82.58%-1.25M |
| -Other fair value changes | ---- | ---184K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 99.73%-29.89K | ---- | -8,948.64%-10.96M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---10.91M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---29.89K | ---- | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---50.75K |
| Depreciation and amortization: | ---- | 15.82%14.41M | ---- | -16.03%12.44M | ---- | -9.07%14.81M | ---- | -3.37%16.29M | ---- | 17.30%16.86M |
| -Depreciation | ---- | 15.82%14.41M | ---- | -16.03%12.44M | ---- | --14.81M | ---- | ---- | ---- | ---- |
| Financial expense | ---- | 48.58%57.84M | ---- | 73.99%38.93M | ---- | -3.59%22.37M | ---- | 36.42%23.21M | ---- | 47.77%17.01M |
| Special items | ---- | -215.50%-6.7M | ---- | -203.81%-2.12M | ---- | -46.51%2.04M | ---- | -76.23%3.82M | ---- | -52.39%16.07M |
| Operating profit before the change of operating capital | ---- | 27.68%-20.47M | ---- | -545.11%-28.3M | ---- | -152.47%-4.39M | ---- | -4.27%8.36M | ---- | 967.58%8.73M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -257.81%-229K | ---- | -123.46%-64K | ---- | 254.61%272.8K | ---- | -1,816.37%-176.44K | ---- | 96.27%-9.21K |
| Accounts receivable (increase)decrease | ---- | 221.65%3.2M | ---- | -567.02%-2.63M | ---- | -102.67%-394.74K | ---- | 288.82%14.79M | ---- | -42.80%3.8M |
| Accounts payable increase (decrease) | ---- | -68.10%2.54M | ---- | 127.58%7.96M | ---- | 235.68%3.5M | ---- | -249.68%-2.58M | ---- | -56.27%1.72M |
| Special items for working capital changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --9.4M | ---- | ---- |
| Cash from business operations | ---- | 35.09%-14.96M | ---- | -2,174.02%-23.04M | ---- | -103.40%-1.01M | ---- | 109.09%29.8M | ---- | -2.79%14.25M |
| Other taxs | ---- | -354.16%-2.57M | ---- | 88.53%-565K | ---- | -254.44%-4.93M | ---- | 36.19%-1.39M | ---- | 56.18%-2.18M |
| Special items of business | -7.60%-22.26M | ---- | 4.86%-20.69M | ---- | -113.14%-21.74M | ---- | -224.67%-10.2M | ---- | 196.65%8.18M | ---- |
| Net cash from operations | -7.60%-22.26M | 25.77%-17.52M | 4.86%-20.69M | -297.52%-23.61M | -113.14%-21.74M | -120.90%-5.94M | -224.67%-10.2M | 135.30%28.41M | 196.65%8.18M | 24.58%12.07M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -50.00%1K | ---- | -97.94%2K | ---- | 8,640.67%96.93K | ---- | -28.54%1.11K | ---- | -26.45%1.55K |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 61.38%-3.47M |
| Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --75.21K | ---- | ---- |
| Purchase of fixed assets | ---- | 63.36%-775K | ---- | 3.48%-2.12M | ---- | -120.69%-2.19M | ---- | 18.60%-992.91K | ---- | 97.26%-1.22M |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -2.14%-237.42K |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --14.93M |
| Other items in the investment business | 98.15%-10K | ---- | -1,077.80%-540K | ---- | -566.20%-45.85K | ---- | -100.06%-6.88K | ---- | 1,233.47%11.57M | ---- |
| Net cash from investment operations | 98.15%-10K | 63.37%-774K | -1,077.80%-540K | -0.89%-2.11M | -566.20%-45.85K | -128.49%-2.09M | -100.06%-6.88K | -109.16%-916.59K | 1,233.47%11.57M | 119.09%10M |
| Net cash before financing | -4.91%-22.27M | 28.86%-18.3M | 2.58%-21.23M | -220.19%-25.72M | -113.45%-21.79M | -129.22%-8.03M | -151.69%-10.21M | 24.53%27.49M | 308.18%19.75M | 151.70%22.08M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | 33.56%469.38M | ---- | 8,101.92%351.43M | ---- | --4.28M | ---- | ---- | ---- | --1.45M |
| Refund | ---- | -19.46%-339.09M | ---- | -2,494.53%-283.85M | ---- | -39.04%-10.94M | ---- | -276.37%-7.87M | ---- | 79.13%-2.09M |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --24.89M |
| Interest paid - financing | ---- | -575.26%-97.65M | ---- | -45.63%-14.46M | ---- | -5.51%-9.93M | ---- | 15.88%-9.41M | ---- | 5.13%-11.19M |
| Issuance expenses and redemption of securities expenses | ---- | ---25.52M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items of the financing business | -59.64%7.47M | ---- | -64.98%18.51M | ---- | 622.44%52.84M | ---- | 65.03%-10.11M | 31.35%-22.02M | -211.40%-28.92M | 49.30%-32.08M |
| Net cash from financing operations | -59.64%7.47M | -88.20%6.15M | -64.98%18.51M | 394.97%52.12M | 622.44%52.84M | 56.30%-17.67M | 65.03%-10.11M | -100.12%-40.43M | -211.40%-28.92M | 76.47%-20.21M |
| Effect of rate | 904.35%7.4M | -489.53%-670K | -196.93%-920K | 114.49%172K | 63.16%-309.84K | -441.17%-1.19M | 4.35%-841.09K | -122.79%-219.4K | -107.75%-879.32K | 4,530.37%962.61K |
| Net Cash | -443.92%-14.8M | -146.01%-12.15M | -108.76%-2.72M | 202.71%26.4M | 252.81%31.05M | -98.62%-25.7M | -121.59%-20.32M | -790.84%-12.94M | 51.15%-9.17M | 101.46%1.87M |
| Begining period cash | -49.21%13.23M | 5,013.40%26.04M | 5,013.49%26.04M | -102.01%-530K | -102.01%-529.99K | -33.30%26.36M | -33.30%26.36M | 7.73%39.52M | 7.73%39.52M | -77.80%36.69M |
| Cash at the end | -74.00%5.83M | -49.21%13.23M | -25.86%22.4M | 5,013.49%26.04M | 481.43%30.21M | -102.01%-529.99K | -82.37%5.2M | -33.30%26.36M | 68.51%29.47M | 7.73%39.52M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.